Items Tagged ‘Triple Negative Breast Cancer’

August 2nd, 2012

FDA Seeks to Speed Drug Development for Early-Stage, Triple-Negative Breast Cancer


In order to speed the availability of promising drugs for high-risk, early-stage breast cancer, the US Food and Drug Administration (FDA) has drafted new guidelines for clinical trials. These guidelines focus specifically on triple-negative breast cancer. Given the limited available treatment options for triple-negative breast cancer, the identification of effective new therapies is an important […]

View full entry

Tags: Breast Cancer, News, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer, Triple Negative Breast Cancer